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ABSTRACT 
 
Kindred cells can have different genomes because of dynamic changes in DNA. Single 
cell sequencing is needed to characterize these genomic differences but has been hindered 
by whole-genome amplification bias, resulting in low genome coverage. Here we report a 
new amplification method: Multiple Annealing and Looping Based Amplification Cycles 
(MALBAC) that offer high uniformity across the genome. Sequencing MALBAC 
amplified DNA achieves 93% genome coverage ≥1x for a single human cell at 25x mean 
sequencing depth. We detected digitized copy number variations (CNVs) of a single 
cancer cell. By sequencing three kindred cells, we were able to call individual single 
nucleotide variations (SNVs) with no false positives observed. We directly measured the 
genome-wide mutation rate of a cancer cell line and found that purine-pyrimidine 
exchanges occurred unusually frequently among the newly acquired SNVs. 
 
 
 
Summary: 
A new whole genome amplification method with significantly reduced bias allows 
simultaneous accurate detection of point mutations and copy number variations in single 
mammalian cells and the direct measurement of mutation rates.3 
 
Single molecule and single cell studies reveal behaviors that are hidden in bulk 
measurements (1, 2). In a human cell, the genetic information is encoded in 46 
chromosomes. The variations occurring in these chromosomes, such as single nucleotide 
variations (SNVs) and copy number variations (CNVs) (3), are the driving forces in 
biological processes such as evolution and cancer. Such dynamic variations are reflected 
in the genomic heterogeneity among a population of cells, which demands 
characterization of genomes at the single cell level (4-6). Single cell genomics analysis is 
also necessary when the number of cells available is limited to few or one, such as 
prenatal testing samples (7, 8), circulating tumor cells (9), and forensic specimens (10).  
 
Prompted by rapid progress in next generation sequencing techniques (11), there have 
been several reports on whole genome sequencing of single cells (12-16). These methods 
have relied on whole genome amplification (WGA) of an individual cell to generate 
enough DNA for sequencing (17-21). However, WGA methods in general are prone to 
amplification bias, which results in low genome coverage. PCR-based WGA introduces 
sequence-dependent bias because of the exponential amplification with random primers 
(17, 18, 22). Multiple Displacement Amplification (MDA), which uses random priming 
and the strand-displacing phi29 polymerase under isothermal condition (19), has 
provided improvements over PCR-based methods but still exhibits considerable bias, 
again due to nonlinear amplification.  
 
Here we report a new WGA method, Multiple Annealing and Looping Based 
Amplification Cycles (MALBAC), which introduces quasi-linear preamplification to 
reduce the bias associated with nonlinear amplification. Picograms of DNA fragments 
(~10 to 100kb) from a single human cell serve as templates for amplification with 
MALBAC (Fig. 1). The amplification is initiated with a pool of random primers, each 
having a common 27-nucleotide sequence and 8 variable nucleotides that can evenly 
hybridize to the templates at 0°C. At an elevated temperature of 65°C, DNA polymerases 
with strand displacement activity are used to generate semiamplicons with variable 
lengths (0.5-1.5kb), which are then melted off from the template at 94°C. Amplification 
of the semiamplicons give full amplicons which have complementary ends. The 
temperature is cycled to 58
 °C to allow the looping of full amplicons, which prevents 
further amplification and cross hybridizations. Five cycles of preamplification are 
followed by exponential amplification of the full amplicons by PCR in order to generate 
micrograms of DNA required for next generation sequencing (Fig. 1). In the PCR, oligos 
with the common 27-nucleotide sequence are used as the primers.  4 
 
We used MALBAC to amplify the DNA of single SW480 cancer cells. With ~25x mean 
sequencing depth, we consistently achieved ~85% and up to 93% genome coverage at 
≥1x depth on either strand (Fig. 2A). As a comparison, we performed MDA on a single 
cell from the same cancer cell line. At 25x mean sequencing depth, MDA covered 72% of 
the genome at ≥1x coverage.  While significant variations of the coverage have been 
reported for MDA (15, 16, 20, 23), MALBAC coverage is reproducible.  
 
We use Lorenz curves to evaluate coverage uniformity along the genome. Here, we 
plotted the cumulative fraction of the total reads that cover a given cumulative fraction of 
genome (Fig. 2B). The diagonal line indicates a perfectly uniform distribution of reads, 
and deviation from the diagonal line indicates an uneven distribution of reads. We 
compared the Lorenz curves for bulk sequencing, MALBAC, and MDA at ~25x mean 
sequencing depth (Fig. 2B). It is evident that MALBAC outperforms MDA in uniformity 
of genome coverage. We also plotted the power spectrum of read density variations to 
show the spatial scale at which the variations take place. For MDA, large amplitudes at 
low frequencies (1/genome distance) were observed, indicating that large contiguous 
regions of the genome are over- or under-amplified. In contrast, MALBAC has a power 
spectrum similar to that of the unamplified bulk.  
 
CNVs due to insertions, deletions, or multiplications of genome segments are frequently 
observed in almost all categories of human tumors (13, 24, 25). MALBAC’s lack of 
large-scale bias makes it amenable to probing CNVs in single cells. We determined the 
digitized CNVs across the whole genomes of three individual cells from the SW480 
cancer cell line (Fig. 3A-C). CNVs of five cells are included in the SOM (Supplemental 
Online Material). The chromosomes exhibit distinct CNV differences among the three 
individual cancer cells and in the bulk result (Fig. 3D), which are difficult to resolve by 
MDA (Fig. 3E). For the MALBAC data, we used a hidden Markov model to quantify 
CNVs (SOM). We confirmed the gross features of CNVs detected by MALBAC with a 
previously published karyotyping study (26). For example, both MALBAC-based 
quantification of CNVs and spectral karyotyping show one copy of chromosome 18 and 
three copies of chromosome 17 in the SW480 cancer cell line.  Although the majority of 
copy numbers are consistent between single cells, we also observe cell-to-cell variations 
as labeled by the dashed box in Fig. 3. 
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Attempts have been made recently to identify SNVs from a single cell by MDA (15, 16, 
23). The first challenge in accurate SNV calling from a single cell is substantial human 
contamination from the environment and the operators, given picograms of DNA from a 
single human cell. The second challenge is low detection yield (high false negative), 
particularly where alleles drop out due to amplification bias. The third challenge is false 
positives associated with amplification and sequencing errors, either random or 
systematic (27). 
 
To meet the first challenge, we took special precautions to decontaminate with UV 
radiation before each experiment was conducted in a restricted clean room. An alternative 
approach to reduce contamination is microfluidics (28). 
 
With regard to the second challenge, MALBAC allowed us to call 2.2 x 10
6 single cell 
SNVs compared with 2.8 x 10
6 detected SNVs in bulk, yielding a 76% detection 
efficiency, in contrast to 41% with MDA (Table 1). This improvement resulted from 
improved uniformity by MALBAC (SOM, Fig S6). Listed separately in Table 1 are 
heterozygous and homozygous SNVs. Next we calculate the allele dropout rate. 
Comparison of single-cell and bulk SNVs showed that 7,288 of the SNVs genotyped as 
homozygous mutations by MALBAC are actually heterozygous in bulk, which 
corresponds to a ~1% allele dropout rate in MALBAC (SOM). In contrast, with MDA we 
found 172,563 incorrect homozygous calls, corresponding to an allele dropout rate of 
~65% (SOM). 
 
Compared to the bulk data, the MALBAC data contains 1.1x10
5 false positives (Table 1) 
out of 3x10
9 bases in the genome. This corresponds to a ~4 x10
-5 false positive rate, 
which is due to the errors made by the polymerases in the semi-amplicons generated in 
first MALBAC cycle and propagated in the later amplification. Although improving the 
polymerase’s error rate is possible, our strategy to reduce the false positive rate was to 
sequence two or three kindred cells derived from the same cell. The simultaneous 
appearance of an SNV in the kindred cells would indicate a true SNV. The false positive 
rate due to uncorrelated random errors can be reduced to ~10
-8 with two kindred cells and 
~10
-12 with three kindred cells.  
 
However, there are false positives due to correlated errors i.e. systematic sequencing and 
amplification errors. We filtered out these errors by comparing two unrelated single cells 6 
that are not from the same lineage (SOM, Figure S5). After this procedure, we can call 
true SNVs of a single cell with no false positives observed (Table 2).  
 
To gain insight into the mutation process in the cancer cells, we clonally expanded a 
single ancestor cell picked from a heterogeneous population of the SW480 cancer cell 
line for 20 generations (Fig. 4A). We extracted DNA from this single cell clonal 
expansion for bulk sequencing, which reflects the genome of the ancestor cell. We then 
picked a single cell from this clone. To detect SNVs acquired by the cell during 
expansion, we grew another four generations to obtain the kindred cells denoted C1 to 
C16. We individually sequenced three kindred cells, C1, C2, and C3 after MALBAC 
amplification. After filtering correlated and uncorrelated errors (Fig. 4B), we detected 35 
unique SNVs shown in Fig. 4C.  
 
We randomly chose 8 out of a total of 35 unique SNVs and confirmed that they are 
neither false positives by Sanger sequencing C4-C6, nor false negatives by Sanger 
sequencing the bulk (Please refer to SOM for Sanger sequencing data). As an example, 
Fig. 4D and 4E shows the MALBAC and Sanger sequencing result of one such SNV.  
 
These 35 unique SNVs are newly acquired during the 20 cell divisions. Adjusting for a 
detection efficiency of 72% for heterozygous SNVs, we estimate that ~49 mutations 
occurred in the 20 generations, yielding a mutation rate of ~2.5 nucleotides per cell 
generation, consistent with our estimation based on the bulk data (SOM). The mutation 
rate of this cancer cell line is about 10 fold higher than the mutation rate estimated based 
on germ line studies (29-31). 
 
Mutations can be transitions (purine<->purine exchange i.e. A<->G or pyrimidine<-
>pyrimidine exchange, i.e. C<->T) or transversions (purine <-> pyrimidine exchanges, 
i.e. A/G<->C/T). Transitions are more common. Surprisingly, we found that the 
transition/transversion (tstv) ratio for the 35 newly acquired SNVs detected is only 0.30, 
whereas the ratio for the total SNVs of this cell line is 2.01, as expected for common 
human mutations (32). To further confirm that this observation is not due to single cell 
amplification, we sequenced the bulk DNA of the original heterogeneous culture (SOM). 
The tstv ratio for SNVs detected in the single cell expanded bulk but not in the original 
heterogeneous bulk was 0.75. Both significantly low tstv ratios indicate that transitions 
are not favored over transversion for newly acquired SNVs in this cancer cell line 
(SOM). While understanding the underlying mechanism of this phenomenon will require 7 
 
similar measurements in other systems, it is evident that, by allowing precise 
characterization of CNVs and SNVs, MALBAC can shed light on the individuality, 
heterogeneity, and dynamics of the genomes of single cells. 
 
 
 
 
 
 
 
Table 1: Comparison of Single cell SNVs for bulk, MDA and MALBAC 
 
 
Heterozygous 
SNVs 
Homozygous 
SNVs  Total SNVs 
Bulk 
SNVs  911,958  1,930,204  2,842,162 
Single cell MDA 
SNVs 
Detection efficiency  
93,140 (2,828)* 
10% 
1,238,286 (1,973) 
63% 
1,331,426 (4,801) 
41% 
Single cell MALBAC  
SNVs 
Detection efficiency  
756,812 (108,481) 
71% 
1,539,326 (6,821) 
 80% 
2,296,138 (115,302) 
76% 
*The number in the bracket indicates the number of false positives. 
 
 
Table 2: MALBAC calling of total SNVs and newly acquired SNVs using two and 
three kindred cells  
  Heterozygous 
SNVs 
Homozygous 
SNVs 
Total SNVs 
Two kindred cells 
SNVs   
Detection efficiency 
Newly acquired SNVs 
615,387  
67% 
145 (~100)* 
1,322,555  
68% 
3 (~0) 
1,937,942 
68% 
148 (~100) 
Three kindred cells 
SNVs   
Detection efficiency 
Newly acquired SNVs 
660,246 
72% 
30 (~0) 
1,577,798 
81% 
5 (~0) 
2,238,044 
80% 
35 (~0) 
*The number in the bracket indicates the number of false positives. 
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Figure Captions: 
 
 
Figure 1: MALBAC single cell whole genome amplification. A single cell is picked and 
lysed.  First, genomic DNA of the single cell is melted into single-stranded DNA 
molecules at 94°C. MALBAC primers then anneal randomly to single-stranded DNA 
molecules at 0°C and are extended by a polymerase with displacement activity at 
elevated temperatures, creating semi-amplicons. In the following five temperature cycles, 
after the step of looping the full amplicons, single stranded amplicons and the genomic 
DNA are used as template to produce full amplicons and additional semi-amplicons, 
respectively. For full amplicons, the 3’ end is complementary to the sequence on the 5’ 
end. The two ends hybridize will form the looped DNA, which can efficiently prevents 
the full amplicon from being used as template, therefore warrant a close-to-linear 
amplification. After the five cycles of linear preamplification, only the full amplicons can 
be exponentially amplified in the following PCR using the common 27-nucleotide 
sequence as the primer. PCR reaction will generate microgram level of DNA material for 
sequencing experiments. 
 
Figure 2. Characterization of amplification uniformity. (A) Histograms of reads over the 
entirety of Chromosome 1 of a single cell from the SW480 cancer cell line and the zoom-
in of a ~8 million base region (chr1: 62,023,147-70,084,845). (B) Lorenz curves of 
MALBAC, MDA and bulk sample. A Lorenz curve gives the cumulated fraction of reads 
as a function of the cumulated fraction of genome. Perfectly uniform coverage would 
result in a diagonal line and a large deviation from the diagonal is indicative of a biased 
coverage. The green and blue arrows indicate the uncovered fractions of the genome for 
MALBAC and MDA respectively. All samples are sequenced at 25x depth. (C) Power 
spectrum of read density throughout the genome (as a function of spatial frequency).  
MALBAC performs similarly to bulk, while the MDA spectrum shows high amplitude at 
low frequency, demonstrating that regions of several megabases suffer from under- and 
over- amplification. This observation is consistent with the variations of read depth in 
Fig. S3 (SOM). 9 
 
 
 
Figure 3. CNVs of single cancer cells. Digitized copy numbers across the genome are 
plotted for three single cells (Panel A to C) as well as the bulk sample (Panel D) from the 
SW480 cancer cell line. The bottom panel shows the result based on MDA amplification 
(Panel E). Green lines are fitted CNV numbers obtained from the hidden Markov model 
(SOM). The single cells are sequenced at only 0.8x depth, while the bulk and MDA are 
done at 25x. More single cells’ CNV analyses are included in the SOM (Fig. S4). The 
regions within the dashed box exhibit the CNV differences among single cells and the 
bulk, which cannot be resolved by MDA. The binning window is 200kb. 
 
Figure 4. Calling newly acquired SNVs and estimation of mutation rate of a cancer cell 
line (SW480). (A) Experiment design. A single ancestor cell is chosen and cultured for 
~20 generations. The vast majority of cells are used to extract DNA for bulk sequencing 
to represent the ancestor cell’s genome.  A single cell from this culture is chosen for 
another expansion of four generations. The kindred cells are isolated for single cell whole 
genome amplification. Single cell sample C1, C2, and C3 are used for high-throughput 
sequencing. Sample C4, C5, and C6 are used for varying SNVs with Sanger sequencing. 
(B) 3D p-value plot of a one-sided binomial test for SNV candidates from the three 
kindred cells. The black dots are the false positives due to uncorrelated amplification 
errors; all of them are on the x-y-z axis and x-y, y-z, x-z planes.  Outside of the three 
planes, the 166 green dots are the residual false positives due to correlated errors from 
homopolymers, tandem repeats, high-GC content and high density SNV regions, and the 
35 red dots are the newly acquired SNVs during the 20 generations of clonal expansion 
(SOM). We note that the homozygous SNVs are located at the (1,1,1) position. (C) 
Locations of the 35 newly acquired SNVs on the chromosomes of a single cell (SOM). 
(D) Next-generation sequencing data of a newly acquired SNV. The SNV (CG) exists 
in the high throughput data of all three kindred cells but not in the bulk data. (E) Sanger 
sequencing data of single cells C4, C5, and C6 confirms that this SNV is not a false 
positive, while the Sanger sequencing of the bulk confirms that this SNV is not a false 
negative of next generation sequencing of the bulk (i.e. this SNV is indeed absent in the 
bulk). 
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